Essa Pharma Inc (NASDAQ:EPIX) has a beta value of 1.84 and has seen 33.54 million shares traded in the last trading session. The company, currently valued at $16.72M, closed the last trade at $1.40 per share which meant it lost -$3.8 on the day or -73.08% during that session. The EPIX stock price is -733.57% off its 52-week high price of $11.67 and -202.86% below the 52-week low of $4.24. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.46 million shares traded. The 3-month trading volume is 58.40K shares.
Essa Pharma Inc (NASDAQ:EPIX) trade information
Sporting -73.08% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the EPIX stock price touched $1.40 or saw a rise of 75.69%. Year-to-date, Essa Pharma Inc shares have moved -78.79%, while the 5-day performance has seen it change -74.77%. Over the past 30 days, the shares of Essa Pharma Inc (NASDAQ:EPIX) have changed -76.86%. Short interest in the company has seen 1.15 million shares shorted with days to cover at 18.62.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have a consensus price target for the stock at $16, which means that the shares’ value could jump 91.25% from current levels. The projected low price target is $15.0 while the price target rests at a high of $17.0. In that case, then, we find that the current price level is -1114.29% off the targeted high while a plunge would see the stock gain -971.43% from current levels.
Essa Pharma Inc (EPIX) estimates and forecasts
Figures show that Essa Pharma Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -79.65% over the past 6 months, with this year growth rate of -18.33%, compared to 18.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 25.04% over the past 5 years.
EPIX Dividends
Essa Pharma Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Essa Pharma Inc (NASDAQ:EPIX)’s Major holders
Insiders own 2.26% of the company shares, while shares held by institutions stand at 80.08% with a share float percentage of 81.94%. Investors are also buoyed by the number of investors in a company, with Essa Pharma Inc having a total of 37.0 institutions that hold shares in the company. The top two institutional holders are BVF INC/IL with over 8.75 million shares worth more than $46.02 million. As of 2024-06-30, BVF INC/IL held 19.7767% of shares outstanding.
The other major institutional holder is BELLEVUE GROUP AG, with the holding of over 7.89 million shares as of 2024-06-30. The firm’s total holdings are worth over $41.5 million and represent 17.8348% of shares outstanding.
